Introduction
Trisomy 18 syndrome (18T, also Edwards syndrome) is the second most frequent autosomal trisomy syndrome in humans. This syndrome involves the presence of an extra chromosome 18 (1). The incidence of 18T is estimated to be 1/6,000-1/8,000 births (2) . This trisomy usually manifests as abnormal development of multiple tissues and organs during prenatal ultrasound screening and is subsequently confirmed by karyotype analysis of cultured amniotic fluid cells (AFC). As a result of recent developments in and clinical use of next-generation sequencing (NGS)-based noninvasive prenatal diagnosis (NIPD) technologies, an unprecedentedly large number of fetuses with 18T have been screened, and 18T has been identified as a leading cause of miscarriages (3) (4) (5) .
Typically, 18T is characterized by significant growth delay, dolichocephaly, specific facies, limb anomalies, and visceral malformations (2) . Chromosome 18 has the lowest gene density among human chromosomes (6) . Unlike other trisomy syndromes such as trisomy 21, knowledge about the pathology and molecular mechanisms of 18T is very limited (7, 8) . This may be partly due to the lack of disease-associated samples and disease models as a result of the syndrome's rareness and extremely high mortality rate (2, 9) .
The recent development of induced somatic cell reprogramming efficiently provides induced pluripotent stem cells (iPSCs) from nearly all types of patientderived somatic cells, allowing researchers to mimic pathological processes by differentiating iPSCs into disease-associated cells. This can provide novel clues to better understand the biological characteristics of many rare diseases such as 18T. A previous study attempted to establish 18T-iPSCs (10) . Although
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Materials and Methods
AFC sampling and ethnical approval
Ten-mL AFC samples were obtained from a pregnant woman who underwent an amniocentesis for prenatal diagnosis at Zibo Maternal and Child Health Hospital in Zibo, Shandong, China. Samples were obtained with the woman's informed consent. 18T was diagnosed after chromosomal microarray analysis. The study protocol has been reviewed and approved by the ethics committee of the Shandong Medical Biotechnological Center, Jinan, Shandong, China. After collection, AFC samples were centrifuged at 200 g for 5 minutes at room temperature, and then the cells were washed and cultured with BIOAMF-2 complete medium (Biological, Inc., Kibbutz Beit Haemek, Israel) at 37℃ in a 5% CO 2 atmosphere.
iPSC reprogramming and culture
iPSCs were generated using the procedure that was previously reported (11) (12) (13) . Briefly, 2 × 10 6 AFC cells were transfected with the plasmids pCXLEhOCT3/4-shp53-F, pCXLE-hSK, pCXLE-hUL, and pCXWB-EBNA1 (kindly provided by Dr. Fabin Han of Liaocheng People's Hospital, Liaocheng, Shandong, China) through electrotransfection (Lonza Nucleofector and Nucleofector Kit V, Lonza, USA). On day 5 post-transduction, BIOAMF-2 culture medium was changed to iM1 (Osinglay, China). Medium was then replenished every day for 3 weeks, and medium was then changed to BioCISO (Osinglay, China) until uniform colonies were generated. The iPSC colonies were collected on day 26.
Characterization of iPSCs using alkaline phosphatase staining, karyotyping, and detection of pluripotency markers
Alkaline phosphatase staining was performed using the BCIP/NBT Kit (CoWin Biosciences, China) after treatment with 4% polyoxymethylene. Karyotyping of 18T-iPSCs was performed as described previously, and the Metafer karyotyping system (Carl Zeiss AG, Jena, Germany) was used to analyze images. The level of expression of the pluripotency biomarkers NANOG, SOX2, and OCT3/4 in 18T-iPSCs and derived AFCs was compared using real-time PCR. The primers used are listed in Table 1 . After dissociation via 0.5-μM EDTA digestion and fixation, flow cytometry analysis was used to examine human pluripotency markers with the following antibodies: anti-Oct4 (BD Biosciences, USA), anti-SSEA4 (BD Biosciences, USA), anti-Tra-1-60 (BD Biosciences, USA), and antiTra-1-81 (BD Biosciences, USA). Flow cytometry was performed using the BD FACS Aria flow cytometer (BD Biosciences, USA).
Embryoid body (EB) formation assay
For an in vitro embryoid body (EB) formation assay, 18T-iPSCs were scraped from plates after dissociation using BioC-PDE1 (Osinglay, China) and cultured in 6-well suspension culture plates with BioCISO-EB1 medium (Osinglay, China) for 7 days to obtain EBs. The EBs were then cultured in 6-well culture plates coated with Matrigel for 7 to 14 days. Cells were then collected, and expression profiles of marker genes in the three germ layers were determined using real-time PCR. Corresponding genes and their primers are listed in Table 1 .
Teratoma formation assay
For an in vivo teratoma formation, iPSCs were cultured to approximately 85% confluence. After 10-15 minutes of dissociation using Bio-PDE1, cells were scraped from the plates. One hundred and thirty μl of culture medium, 70 μL of Matrigel, and the cell suspension were subcutaneously injected into NOD/SCID mice. After 4-6 weeks, mice were sacrificed, and tumors that developed were fixed in formalin for 24 h and then embedded in paraffin. The specimens were stained with hematoxylin and eosin.
Transcriptomic profiles according to RNA sequencing
The global gene expression profiles of 18T-iPSCs and two normal iPSC lines established from ATCs by this Laboratory were analyzed using RNA-Seq technology. Briefly, total RNA was extracted using the TRIzol reagent (Invitrogen), a library was constructed, and RNA was sequenced with the Illumina HiseqX platform (illumine, USA). RNA sequencing data were expressed as fragments per kilobase of exon per million fragments mapped (FPKM). The Benjamini-Hochberg false discovery rate (FDR) threshold ≤ 0.05 and log2 fold change ≤ -1 or ≥ 1 based on DESeq-normalized read counts were used as criteria to determine differentially expressed genes. and lungs) was found to be differently expressed in 18T-iPSCs compared to normal iPSCs, and these differences in expression may partly account for the comprehensive malformations caused by 18T.
Discussion
The current study successfully generated an iPSC line from 18T AFCs. Findings indicated that these 18T-iPSCs were alkaline phosphatase-positive and significantly expressed pluripotency biomarkers such as NANOG, SOX2, OCT3/4, and SSEA4. As further corroboration, these 18T-iPSCs have the potential to differentiate into three germ layers both in vitro and in vivo. Unlike the 18T-iPS cell line established by Li et al. (10) , the current cell line exhibited stable trisomy after numerous passages. Therefore, the 18T-iPSCs generated in the current study are more representative of 18T.
The current study also observed the genomic instability of 18T-iPSCs in another iPSC line derived from the same AFCs with 18T pregnancies. Although those cells exhibited pluripotency, they spontaneously gained an extra chromosome 8 after more than 10 passages. The current findings confirmed the contention that 18T cells are prone to spontaneously differentiating, but they have built upon results of previous studies by revealing an extra trisomy mutation. Therefore, whether the 18T-iPSCs established here would exhibit genomic instability after more passages is a question that warrants study.
18T is an aberrantly differentiated condition with complicated malformations, and the exact molecular mechanism by which an extra 18 chromosome causes that pathology is not clear (10) . Interestingly, the current transcriptomic findings indicated that the gene expression of 18T-iPSCs varied significantly from that in normal iPSCs, but the genes in question were not limited to those located on chromosome 18. Moreover, differentiation-associated genes were markedly dysregulated in 18T-iPSCs, suggesting that 18T may involve an aberrant genetic background in the ES cell stage.
In conclusion, this study successfully established a representative 18T-iPSC clone, and it described the molecular characteristics of that clone at the transcriptomic level for the first time. These findings should provide more information with which to understand the pathology of 18T. This 18T-iPSC clone also provides a useful tool with which to study aberrant multi-lineage differentiation in 18T.
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Results
The induction of iPSCs from 18T-derived AFCs is summarized in Figures 1A . Figure 1B-1D shows the characteristic morphological changes during iPSC induction from AFCs. At 26-32 days of induction, the 18T-iPSCs were purified and exhibited typical phenotypes like embryonic stem (ES) cells ( Figure  1D ).
After 18 passages, the 18T-iPSCs exhibited stable 18T karyotypes ( Figure 1E ). Alkaline phosphatasepositive ES cell-like colonies of 18T-iPSCs were noted ( Figure 1F) , and real-time PCR and flow cytometry staining revealed significant expression of pluripotent markers (Figures 1F-G) . In addition, the generated 18T-iPSCs were found to have differentiated into all three germ layers according to the in vitro EB formation assay and the in vivo teratoma formation assay ( Figure  2D ). Taken together, these findings indicate that the established 18T-iPS cell line has obvious pluripotency while maintaining trisomy.
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